NEUROMYELITIS OPTICA

Clinical trials for NEUROMYELITIS OPTICA explained in plain language.

Never miss a new study

Get alerted when new NEUROMYELITIS OPTICA trials appear

Sign up with your email to follow new studies for NEUROMYELITIS OPTICA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 3 Completed 1

New attack on rare nerve disease tests faster steroid withdrawal

Disease control Not yet recruiting

This study is testing a drug called inectolizumab (inebilizumab) in people experiencing their first attack of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that damages the nerves. The main goal is to see if the drug allows patients to safely stop taki…

Matched conditions: NEUROMYELITIS OPTICA

Phase: NA • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control

Last updated Apr 02, 2026 00:42 UTC

NEUROMYELITIS OPTICA

Get alerted when new NEUROMYELITIS OPTICA trials appear

New attack on rare nerve disease tests faster steroid withdrawal